Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for ...

A new at-home spit test for prostate cancer may be better than current blood tests, a new study shows. The simple saliva test has been developed by experts and works by analysing genetic variants in a ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...

While prostate cancer is the most common form of cancer, the most common way of screening for the disease is under question from many in the medical community. Gerald Andriole, MD, chief of urology at ...

Credit: Getty Images Determining the presence or absence of gene mutations associated with aggressive prostate cancer can have implications for risk stratification, monitoring, and therapy. Genetic ...

One out of every nine men—that’s how many will be diagnosed with prostate cancer in their lifetime. Most of those cases will be low risk—involving tumors that grow slowly and aren’t very aggressive.

Prostate cancer is a serious health concern that affects men of all races and backgrounds. However, research has shown that Black men are at a higher risk of developing prostate cancer and ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

In this prospective cohort study, men with mPC provided informed consent via an Internet-based platform and completed a questionnaire including demographics and family cancer history. Supporting ...